(UroToday.com) The 2026 ESMO annual meeting featured a prostate cancer session and a presentation by Dr. Neal Shore ...

Twenty patients with metastatic chRCC received first-line lenvatinib plus pembrolizumab. The median age was 63 years, and all ...

(UroToday.com) The 2026 ESMO annual meeting featured a prostate cancer session and a presentation by Dr. Ricardo ...

Using PHS as a continuous variable, 24 week maximally changed cognitive domain in CANTAB showed no significant correlation ...

(UroToday.com) The 2026 North Central Section of the AUA annual meeting featured a prostate cancer session and a presentation ...

The 2026 North Central Section of the AUA annual meeting featured a urothelial carcinoma session and a presentation by Dr.

The 2026 North Central Section of the AUA annual meeting featured a bladder cancer session and a presentation by Dr. Kaitlin Davis discussing regional disparities in bladder cancer mortality rates.

Daniel Spratt and Alicia Morgans discuss clinical outcomes of patients with Gleason score 9-10 prostate cancer after definitive treatment. Long-term Survival in Men with Gleason Score 9-10 Treated ...

Spatial Architecture Contributes to Failure of Bulk Biomarker-Guided Neoadjuvant Immunotherapy Selection in Bladder Cancer: The DUTRENEO Study - Beyond the Abstract ...

Chronic prostatitis/chronic pelvic pain syndrome: Interplay of inflammatory mediators, "Beyond the Abstract," by Dan Lundh, Hans Hedelin, and Dennis Larsson ...

Comprehensive Analysis of microRNA Expression Provides Mechanistic Insights into Transcriptomic Alteration in Primary and Metastatic Testicular Germ Cell Tumors - Beyond the Abstract ...

The Kurt extraperitoneal ligamentopexy: A new surgical method with uterine preservation for pelvic organ prolapse, "Beyond the Abstract," by Sefa Kurt and Mehmet Tunc Canda ...